Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2022 / Jan / Seeing Dementia Burden Clearly
Anterior Segment Cataract Neuro-ophthalmology

Seeing Dementia Burden Clearly

How does cataract removal affect the risk of developing dementia?

By Geoffrey Potjewyd 1/10/2022 1 min read

Share

Diseases of aging tend not to be found in isolation; comorbidity is common, with one or more diseases exacerbating the progression of others in a damaging feedback loop of pathology. Vision loss and dementia have long been tied together in this way, with poor eyesight often leading to isolation and inactivity that can accelerate dementia. Dementia already places a huge burden on healthcare systems, as well as patients and their families – and this burden is only set to rise with an increasingly aged population.

Evasive “cataraction”


So, is it possible to tackle the growing rates of dementia by targeting cataracts? In the first study to directly explore the relationship, researchers from the University of Washington, USA, found that cataract removal significantly reduces the risk of the patient developing dementia (1). The researchers analyzed a large pool of data from the Adult Changes in Thought study; specifically, the team assessed 3,038 participants, all of whom were over the age of 65 with glaucoma or cataracts before enrollment. Interestingly, glaucoma surgery did not appear to affect the risk of dementia developing, but those who had cataract surgery had close to a 30 percent lower risk, which persisted beyond 10 years.

The authors suggest that both increased quantity and quality of light may be behind the significant effect of cataract surgery on dementia risk. In particular, blue light, which acts on photosensitive retinal ganglion cells, is associated with positive measures in cognitive function and Alzheimer’s disease; the researchers note that the yellow hue of cataracts blocks blue light, possibly speeding the onset of dementia by inhibiting mental stimulation.

Healthy heart, healthy brain?


Another potential explanation (or co-conspirator) is the role of vascular health; visual impairment can be accompanied by a reduction in mobility and activity, which contributes towards poor vascular health – a major risk factor for dementia onset and progression. The removal of cataracts and the recovery of vision may enable more active and healthy lifestyles, increasing vascular health and thus reducing dementia risk.

The researchers admit that further research is needed to determine the mechanism of action. But, whatever the reason, their work provides another reason why cataract surgery is so important – if further justification were ever needed.

References

  1. CS Lee et al., JAMA Intern Med, e216990 (2021). PMID: 34870676.

About the Author(s)

Geoffrey Potjewyd

The lion’s share of my PhD was spent in the lab, and though I mostly enjoyed it (mostly), what I particularly liked was the opportunity to learn about the latest breakthroughs in research. Communicating science to a wider audience allows me to scratch that itch without working all week only to find my stem cell culture has given up the ghost on the Friday (I’m not bitter). Fortunately for me, it turns out writing is actually fun – so by working for Texere I get to do it every day, whilst still being an active member of the clinical and research community.

More Articles by Geoffrey Potjewyd

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: